DEVICE FOR BLOOD CANNULATION FOR HAEMODIALYSIS

Worldwide, there are more than 850 million people with severe kidney disease. This number is increasing due to the rise in chronic diseases such as diabetes and cancer. Vascular access is essential for perform haemodialysis (HD) in the patient treatment of kidney disease. Currently, these accesses are performed via a catheter, an arteriovenous graft or an arteriovenous fistula (AVF). Although the latter are the safest and longest lasting, they have significant limitations, including long maturation times, vascular deformation, thrombus, infection, and implant location problems. Researchers from the company Klus Life Systems SLU, Valencia University and INCLIVA Biomedical Research Institute have developed a device consisting of a universal blood channelling system for haemodialysis that guarantees a homogeneous, continuous and orderly flow, reducing the risks associated with current techniques.